Published on Swiss Biotech Report 2023, April 25th

Biotech is the key growth area for pharma and lifescience, and Swissbased biotech companies play a major role across the entire development cycle, from their share of the pipeline, to clinical trial activity, to the emerging commercialization of new molecules.
Switzerland's ability to drive and nurture innovation is continuing to expand.
Read this article to learn more on the Switzerland's contributions to biotech commercial success.